Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MGEN

Miragen Therapeutics (MGEN) Stock Price, News & Analysis

Miragen Therapeutics logo

About Miragen Therapeutics Stock (NASDAQ:MGEN)

Advanced Chart

Key Stats

Today's Range
$14.98
$15.94
50-Day Range
$14.34
$23.01
52-Week Range
$4.66
$34.05
Volume
396,663 shs
Average Volume
134,027 shs
Market Capitalization
$61.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Miragen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MGEN Stock News Headlines

Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Viridian Therapeutics Inc (VRDN)
See More Headlines

MGEN Stock Analysis - Frequently Asked Questions

Miragen Therapeutics, Inc. (NASDAQ:MGEN) issued its earnings results on Tuesday, November, 10th. The medical research company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.03. Miragen Therapeutics had a negative trailing twelve-month return on equity of 141.66% and a negative net margin of 1,393.50%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Miragen Therapeutics investors own include Sorrento Therapeutics (SRNE), OPKO Health (OPK), Nokia (NOK), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX) and Pfizer (PFE).

Company Calendar

Last Earnings
11/10/2020
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MGEN
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.87 million
Net Margins
-1,393.50%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.46 million
Price / Cash Flow
N/A
Book Value
$6.78 per share
Price / Book
2.31

Miscellaneous

Free Float
N/A
Market Cap
$61.24 million
Optionable
Not Optionable
Beta
1.66
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:MGEN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners